According to Taro Pharmaceutical's latest financial reports the company has a price-to-book ratio of 0.8945.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2023-12-31 | 0.8826 | 37.98% |
2022-12-31 | 0.6397 | -42.38% |
2021-12-31 | 1.11 | -30.82% |
2020-12-31 | 1.60 | -2.05% |
2019-12-31 | 1.64 | -8.46% |
2018-12-31 | 1.79 | -6.1% |
2017-12-31 | 1.91 | -11.66% |
2016-12-31 | 2.16 | -42.14% |
2015-12-31 | 3.73 | -22.32% |
2014-12-31 | 4.80 | 2.97% |
2013-12-31 | 4.66 | 83.34% |
2012-12-31 | 2.54 | 10.51% |
2011-12-31 | 2.30 | 41.71% |
2010-12-31 | 1.62 | 37.73% |
2009-12-31 | 1.18 | -35.87% |
2008-12-31 | 1.84 | |
2005-12-31 | 3.20 | 18.75% |
2004-12-31 | 2.69 | -49.71% |
2003-12-31 | 5.35 | 33.85% |
2002-12-31 | 4.00 |
Company | P/B ratio | differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | 5.54 | 519.68% | ๐บ๐ธ USA |
Novartis NVS | 4.23 | 372.83% | ๐จ๐ญ Switzerland |
Pfizer PFE | 1.76 | 96.75% | ๐บ๐ธ USA |
Merck MRK | 8.88 | 892.72% | ๐บ๐ธ USA |
GlaxoSmithKline GSK | 5.38 | 501.72% | ๐ฌ๐ง UK |
Teva Pharmaceutical Industries TEVA | 1.95 | 117.62% | ๐ฎ๐ฑ Israel |